Patient data reviews faster for docs using EHRs

Primary care physicians with electronic health records were able to identify patients who needed preventative or follow-up care 30 times faster than physicians using paper based medical records, according to a recently published study commissioned by the Canadian Health Infoway, an independent not-for-profit organization funded by the federal government to help accelerate the development and adoption of information and communications technology projects in Canada.

The researchers challenged physicians in five provinces to review their records to identify patients who would benefit from six types of evidence-based interventions: immunizations, follow up after a heart attack, cancer screening, diabetes management, and two medication recalls.

The practices using EHRs conducted a full review in an average of 1.4 hours. The paper based practices of about the same size reviewed only 10 percent of their records in 3.9 hours, which means it would have taken them about 40 hours to conduct a full review. The physicians using EHRs also were more confident in the accuracy of the reviews.

"Using an electronic medical record gives me the peace of mind of knowing I can more quickly identify patients who would benefit from immunizations or other preventive care, as well as those who might be impacted by events such as a medication recall," said Dr. Michael Golbey, Family Physician and Chair of Canada Health Infoway's Clinical Council.

The evidence that EHRs improve patient care continues to mount, from customizing care for chronic conditions to reducing medical errors to facilitating genetic testing.

To learn more:
- here's the announcement
- check out this article on reducing errors
- learn more about inroads in genetic testing
- learn more about improvements in care for chronic conditions

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.